First FDA-Approved Peanut Allergy Drug Shows Manufacturing Innovation
Get the Latest NewsSign Up Here
Last week, the first drug to treat life-threatening peanut allergies was approved by the Food and Drug Administration, offering families and children new protection against potentially deadly reactions.
The therapy, manufactured by Aimmune Therapeutics, opens the door to additional remedies that may change how food allergies are treated and give millions of people the chance to enjoy experiences like plane travel and meals at a restaurant without worrying about dangerous inadvertent exposure or cross-contamination. Aimmune is working on additional food allergy treatments as well, offering hope to individuals who suffer from a range of severe allergies.
This new development is an example of the manufacturing industry’s capacity for innovation, and a reminder of the importance of research and development. Currently, pharmaceutical manufacturers in the United States spend more on research and development than any other industry. With approximately 1,100 facilities in the United States, pharmaceutical manufacturers are leading a period of significant medical breakthrough.
“As the employers of nearly 13 million Americans, manufacturers care deeply about lowering the cost of health care—and as the innovators behind many revolutionary medicines, manufacturers are also committed to delivering lifesaving and life-changing cures for people in this country and around the world,” said Jay Timmons, president and CEO of the National Association of Manufacturers. “In order to continue that work, we need policymakers to take an approach to drug pricing that protects our ability to provide quality health care and spur innovation, not squash it.”
Some approaches to lowering drug prices, such as international price indexing, which is a form of price fixing, would have adverse effects by preventing manufacturers from investing in life-saving innovations. These price controls act as a tax on manufacturers, leaving less money for research and development and fewer investments in potential cures for debilitating conditions and illnesses that affect millions of vulnerable people.
Instead, manufacturers urge policymakers to take more constructive solutions that preserve American innovation and quality of care.
“The men and women who keep U.S. manufacturing facilities running go to work every day with one goal: to keep Americans healthy,” said Timmons. “We know that our elected leaders share that goal as well, but good intentions must be paired with good policy.”
Manufacturers Unveil Competitiveness Agenda Ahead of Midterm Elections
“Competing to Win” offers a path for bringing the country together around policies, shared values and a unified purpose
Washington, D.C. – Ahead of the midterm elections, the National Association of Manufacturers released its policy roadmap, “Competing to Win,” a comprehensive blueprint featuring immediate solutions for bolstering manufacturers’ competitiveness. It is also a roadmap for policymakers on the laws and regulations needed to strengthen the manufacturing industry in the months and years ahead.
With the country facing rising prices, snarled supply chains and geopolitical turmoil, manufacturers are outlining an actionable competitiveness agenda that Americans across the political spectrum can support. “Competing to Win” includes the policies manufacturers in America will need in place to continue driving the country forward.
“‘Competing to Win’ offers a path for bringing our country together around policies, shared values and a unified purpose,” said NAM President and CEO Jay Timmons. “The NAM is putting forward a plan filled with ideas that policymakers could pursue immediately, including solutions to urgent problems, such as energy security, immigration reform, supply chain disruptions, the ongoing workforce shortage and more. Manufacturers have shown incredible resilience through difficult times, employing more workers now than before the pandemic, but continued resilience is not guaranteed without the policies that are critical to the state of manufacturing in America.”
The NAM and its members will leverage “Competing to Win” to shape policy debates ahead of the midterm elections, in the remainder of the 117th Congress and at the start of the 118th Congress—including in direct engagement with lawmakers, for grassroots activity, across traditional and digital media and through events in key states and districts as we did following the initial rollout of the roadmap in 2016.
The document focuses on 12 areas of action, and all policies are rooted in the values that have made America exceptional and keep manufacturing strong: free enterprise, competitiveness, individual liberty and equal opportunity.
Learn more about how manufacturers are leading and about the industry’s competitiveness agenda at nam.org/competing-to-win.
The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.8 million men and women, contributes $2.77 trillion to the U.S. economy annually and accounts for 58% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org